Scientific Platform Pasteur-USP
The Scientific Platform Pasteur-USP (SPPU) carries out studies especially focused on emerging and neglected infectious diseases that are transmitted by pathogens that cause complex immune responses, produce nervous system disorders, and impact human and animal public health.
The SPPU works as an Emergency Cell and its main objective is to curb epidemics of those diseases by developing preventive, diagnostic/prognostic, and therapeutic methods.
Located in the Inova USP Research and Innovation Center, University of São Paulo, in Brazil, in a 1,700 m² area, the Platform consists of 17 laboratories, four of which are biosecurity level 3 (NB3) – comparable to the European standard.
The researchers involved with the SPPU share their areas of expertise, infrastructure, and cutting-edge equipment. This approach goal is to strengthen the development of joint initiatives with a view to discovering new products and processes, as well as to transferring and applying those innovations.
The SPPU is the result of a tripartite agreement between the Pasteur Institute, the University of São Paulo (USP), and the Oswaldo Cruz Foundation (Fiocruz).
For more information, visit the SPPU official website .